Supha Pharmachem (BOM:539561) Total Receivables: ₹13,529 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539561 Supha Pharmachem Ltd BOM:539561
54 GF Score
Price ₹0.32
GF Value ₹1.52
Valuation Possible Value Trap
! 12 Warning Signs
View Full Analysis

What is Supha Pharmachem Total Receivables?

Supha Pharmachem BOM:539561 -3.03% 54 Total Receivables is ₹13,529 Mil as of Sep. 2025. GuruFocus rates BOM:539561 with a GF Score™ of 54/100 and a GF Value™ of ₹1.52 (Possible Value Trap). The stock has 12 warning signs investors should review.

Supha Pharmachem's Total Receivables for the quarter that ended in Sep. 2025 was ₹13,529 Mil.

Supha Pharmachem Total Receivables Related Terms

Supha Pharmachem Total Receivables Historical Data

* Premium members only.

The historical data trend for Supha Pharmachem's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supha Pharmachem Total Receivables Chart

Supha Pharmachem Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 236.84 639.96 1,723.74 9,206.02 7,716.20

Supha Pharmachem Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18,399.91 0.00 7,716.20 0.00 13,529.13
BOM:539561
54GF Score
Supha Pharmachem Ltd BOM:539561
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supha Pharmachem Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹13,529 Mil mean?
Supha Pharmachem (BOM:539561) has a Total Receivables of ₹13,529 Mil as of Sep. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Supha Pharmachem and its competitors.
Is Supha Pharmachem's Total Receivables too high?
Supha Pharmachem's current Total Receivables is ₹13,529 Mil. Overall, Supha Pharmachem has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Supha Pharmachem's Total Receivables compare to ZTS?
Supha Pharmachem's Total Receivables of ₹13,529 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Supha Pharmachem and its competitors. Supha Pharmachem's current Total Receivables is ₹13,529 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supha Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Supha Pharmachem (BOM:539561) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1.52, compared to a current price of ₹0.32 — trading 78.9% below its estimated fair value. The current Total Receivables is ₹13,529 Mil. Supha Pharmachem's overall GF Score™ is 54/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Supha Pharmachem (BOM:539561), the current Total Receivables is ₹13,529 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supha Pharmachem (BOM:539561) Overvalued in 2026?

Based on GuruFocus' analysis, Supha Pharmachem stock appears to be undervalued. The current stock price of ₹0.32 is trading 78.9% below its estimated GF Value™ of ₹1.52. GuruFocus considers Supha Pharmachem to be Possible Value Trap.

Key valuation signals for BOM:539561:

  • Total Receivables: ₹13,529 Mil
  • GF Value™: ₹1.52 vs. price of ₹0.32 (78.9% below fair value)
  • GF Score™: 54/100 with 12 warning signs

No single metric tells the full story. See the BOM:539561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Supha Pharmachem Business Description

Address Saugbaug Road, Office No. 9, Behind Ravi Vihar Hotel, K Raheja Prime, Marol Industrial Estate, Andheri (East), Mumbai, MH, IND, 400059
Supha Pharmachem Ltd, formerly known as Remedium Lifecare Ltd, is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).
54GF Score

Get the complete analysis for BOM:539561

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.32
Price
₹1.52
GF Value